nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Irinotecan—pancreatic cancer	0.591	0.624	CbGbCtD
Pralidoxime—BCHE—Irinotecan—pancreatic cancer	0.356	0.376	CbGbCtD
Pralidoxime—Inflammation—Tamoxifen—pancreatic cancer	0.0026	0.0485	CcSEcCtD
Pralidoxime—Inflammation—Erlotinib—pancreatic cancer	0.00257	0.048	CcSEcCtD
Pralidoxime—Inflammation—Fluorouracil—pancreatic cancer	0.00176	0.0328	CcSEcCtD
Pralidoxime—Muscular weakness—Sunitinib—pancreatic cancer	0.00138	0.0258	CcSEcCtD
Pralidoxime—Haemoglobin—Tamoxifen—pancreatic cancer	0.00127	0.0237	CcSEcCtD
Pralidoxime—Inflammation—Docetaxel—pancreatic cancer	0.00127	0.0236	CcSEcCtD
Pralidoxime—Haemorrhage—Tamoxifen—pancreatic cancer	0.00127	0.0236	CcSEcCtD
Pralidoxime—Haemoglobin—Erlotinib—pancreatic cancer	0.00126	0.0235	CcSEcCtD
Pralidoxime—Haemorrhage—Erlotinib—pancreatic cancer	0.00125	0.0234	CcSEcCtD
Pralidoxime—Hyperventilation—Epirubicin—pancreatic cancer	0.00121	0.0225	CcSEcCtD
Pralidoxime—Hyperventilation—Doxorubicin—pancreatic cancer	0.00112	0.0208	CcSEcCtD
Pralidoxime—Muscular weakness—Fluorouracil—pancreatic cancer	0.00109	0.0203	CcSEcCtD
Pralidoxime—Haemoglobin—Sunitinib—pancreatic cancer	0.00109	0.0203	CcSEcCtD
Pralidoxime—Haemorrhage—Sunitinib—pancreatic cancer	0.00109	0.0202	CcSEcCtD
Pralidoxime—Haemoglobin—Irinotecan—pancreatic cancer	0.000898	0.0167	CcSEcCtD
Pralidoxime—Haemorrhage—Irinotecan—pancreatic cancer	0.000894	0.0167	CcSEcCtD
Pralidoxime—Haemoglobin—Gemcitabine—pancreatic cancer	0.000875	0.0163	CcSEcCtD
Pralidoxime—Haemorrhage—Gemcitabine—pancreatic cancer	0.000871	0.0162	CcSEcCtD
Pralidoxime—Haemoglobin—Fluorouracil—pancreatic cancer	0.000861	0.016	CcSEcCtD
Pralidoxime—Haemorrhage—Fluorouracil—pancreatic cancer	0.000856	0.016	CcSEcCtD
Pralidoxime—Inflammation—Epirubicin—pancreatic cancer	0.000856	0.0159	CcSEcCtD
Pralidoxime—Inflammation—Doxorubicin—pancreatic cancer	0.000792	0.0148	CcSEcCtD
Pralidoxime—Pain—Tamoxifen—pancreatic cancer	0.00077	0.0143	CcSEcCtD
Pralidoxime—Pain—Erlotinib—pancreatic cancer	0.000762	0.0142	CcSEcCtD
Pralidoxime—Vision blurred—Fluorouracil—pancreatic cancer	0.000702	0.0131	CcSEcCtD
Pralidoxime—Pain—Sunitinib—pancreatic cancer	0.000659	0.0123	CcSEcCtD
Pralidoxime—Haemoglobin—Docetaxel—pancreatic cancer	0.000621	0.0116	CcSEcCtD
Pralidoxime—Haemorrhage—Docetaxel—pancreatic cancer	0.000618	0.0115	CcSEcCtD
Pralidoxime—Diplopia—Epirubicin—pancreatic cancer	0.000602	0.0112	CcSEcCtD
Pralidoxime—Dizziness—Tamoxifen—pancreatic cancer	0.000595	0.0111	CcSEcCtD
Pralidoxime—Tachycardia—Fluorouracil—pancreatic cancer	0.000594	0.0111	CcSEcCtD
Pralidoxime—Dizziness—Erlotinib—pancreatic cancer	0.000589	0.011	CcSEcCtD
Pralidoxime—Somnolence—Irinotecan—pancreatic cancer	0.000565	0.0105	CcSEcCtD
Pralidoxime—Headache—Tamoxifen—pancreatic cancer	0.000564	0.0105	CcSEcCtD
Pralidoxime—Headache—Erlotinib—pancreatic cancer	0.000558	0.0104	CcSEcCtD
Pralidoxime—Diplopia—Doxorubicin—pancreatic cancer	0.000557	0.0104	CcSEcCtD
Pralidoxime—Somnolence—Gemcitabine—pancreatic cancer	0.00055	0.0103	CcSEcCtD
Pralidoxime—Pain—Irinotecan—pancreatic cancer	0.000543	0.0101	CcSEcCtD
Pralidoxime—Somnolence—Fluorouracil—pancreatic cancer	0.000541	0.0101	CcSEcCtD
Pralidoxime—Nausea—Tamoxifen—pancreatic cancer	0.000535	0.00997	CcSEcCtD
Pralidoxime—Muscular weakness—Epirubicin—pancreatic cancer	0.000531	0.00991	CcSEcCtD
Pralidoxime—Pain—Gemcitabine—pancreatic cancer	0.000529	0.00986	CcSEcCtD
Pralidoxime—Nausea—Erlotinib—pancreatic cancer	0.000529	0.00986	CcSEcCtD
Pralidoxime—Pain—Fluorouracil—pancreatic cancer	0.00052	0.0097	CcSEcCtD
Pralidoxime—Dizziness—Sunitinib—pancreatic cancer	0.00051	0.0095	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—pancreatic cancer	0.000492	0.00916	CcSEcCtD
Pralidoxime—Headache—Sunitinib—pancreatic cancer	0.000483	0.009	CcSEcCtD
Pralidoxime—Drowsiness—Epirubicin—pancreatic cancer	0.000464	0.00865	CcSEcCtD
Pralidoxime—Nausea—Sunitinib—pancreatic cancer	0.000458	0.00854	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—pancreatic cancer	0.00043	0.00801	CcSEcCtD
Pralidoxime—Tachycardia—Docetaxel—pancreatic cancer	0.000428	0.00799	CcSEcCtD
Pralidoxime—Dizziness—Irinotecan—pancreatic cancer	0.00042	0.00783	CcSEcCtD
Pralidoxime—Haemoglobin—Epirubicin—pancreatic cancer	0.000419	0.00781	CcSEcCtD
Pralidoxime—Haemorrhage—Epirubicin—pancreatic cancer	0.000417	0.00777	CcSEcCtD
Pralidoxime—Dizziness—Fluorouracil—pancreatic cancer	0.000402	0.0075	CcSEcCtD
Pralidoxime—Headache—Irinotecan—pancreatic cancer	0.000398	0.00742	CcSEcCtD
Pralidoxime—Somnolence—Docetaxel—pancreatic cancer	0.00039	0.00728	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—pancreatic cancer	0.000388	0.00723	CcSEcCtD
Pralidoxime—Headache—Gemcitabine—pancreatic cancer	0.000388	0.00722	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—pancreatic cancer	0.000386	0.00719	CcSEcCtD
Pralidoxime—Headache—Fluorouracil—pancreatic cancer	0.000381	0.0071	CcSEcCtD
Pralidoxime—Nausea—Irinotecan—pancreatic cancer	0.000377	0.00703	CcSEcCtD
Pralidoxime—Pain—Docetaxel—pancreatic cancer	0.000375	0.007	CcSEcCtD
Pralidoxime—Nausea—Gemcitabine—pancreatic cancer	0.000367	0.00685	CcSEcCtD
Pralidoxime—Nausea—Fluorouracil—pancreatic cancer	0.000361	0.00673	CcSEcCtD
Pralidoxime—Vision blurred—Epirubicin—pancreatic cancer	0.000342	0.00637	CcSEcCtD
Pralidoxime—Agitation—Epirubicin—pancreatic cancer	0.000333	0.00622	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—pancreatic cancer	0.000316	0.0059	CcSEcCtD
Pralidoxime—Agitation—Doxorubicin—pancreatic cancer	0.000309	0.00575	CcSEcCtD
Pralidoxime—Dizziness—Docetaxel—pancreatic cancer	0.00029	0.00541	CcSEcCtD
Pralidoxime—Tachycardia—Epirubicin—pancreatic cancer	0.000289	0.00539	CcSEcCtD
Pralidoxime—Headache—Docetaxel—pancreatic cancer	0.000275	0.00513	CcSEcCtD
Pralidoxime—Tachycardia—Doxorubicin—pancreatic cancer	0.000267	0.00498	CcSEcCtD
Pralidoxime—Somnolence—Epirubicin—pancreatic cancer	0.000263	0.00491	CcSEcCtD
Pralidoxime—Nausea—Docetaxel—pancreatic cancer	0.000261	0.00486	CcSEcCtD
Pralidoxime—Pain—Epirubicin—pancreatic cancer	0.000253	0.00472	CcSEcCtD
Pralidoxime—Somnolence—Doxorubicin—pancreatic cancer	0.000244	0.00454	CcSEcCtD
Pralidoxime—Pain—Doxorubicin—pancreatic cancer	0.000234	0.00437	CcSEcCtD
Pralidoxime—Dizziness—Epirubicin—pancreatic cancer	0.000196	0.00365	CcSEcCtD
Pralidoxime—Headache—Epirubicin—pancreatic cancer	0.000186	0.00346	CcSEcCtD
Pralidoxime—Dizziness—Doxorubicin—pancreatic cancer	0.000181	0.00338	CcSEcCtD
Pralidoxime—Nausea—Epirubicin—pancreatic cancer	0.000176	0.00328	CcSEcCtD
Pralidoxime—Headache—Doxorubicin—pancreatic cancer	0.000172	0.0032	CcSEcCtD
Pralidoxime—Nausea—Doxorubicin—pancreatic cancer	0.000163	0.00303	CcSEcCtD
